{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:39:51Z","timestamp":1792669191996,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s11136-026-04414-6","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:55:57Z","timestamp":1792666557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determining the minimal important difference of EQ-5D-5\u00a0L utility values in CIDP patients using data from a large clinical trial"],"prefix":"10.1007","volume":"35","author":[{"given":"Febe","family":"Brackx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Arvin-Berod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Istas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Maria","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bosmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dewilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"4414_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/JNS.12455\/SUPINFO","volume":"26","author":"PYK Van den Bergh","year":"2021","unstructured":"n den Bergh, P. Y. K., van Doorn, P. A., Hadden, R. D. M., et al. (2021). European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force\u2014Second revision. Journal of the Peripheral Nervous System, 26, 242\u2013268. https:\/\/doi.org\/10.1111\/JNS.12455\/SUPINFO","journal-title":"Journal of the Peripheral Nervous System"},{"key":"4414_CR2","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1007\/s00415-020-09998-8","volume":"268","author":"L Querol","year":"2021","unstructured":"Querol, L., Crabtree, M., Herepath, M., et al. (2021). Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). Journal Of Neurology, 268, 3706\u20133716.","journal-title":"Journal Of Neurology"},{"key":"4414_CR3","unstructured":"EuroQOL Research Foundation EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument. https:\/\/euroqol.org\/publications\/user-guides"},{"key":"4414_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","volume":"21","author":"M Kennedy-Martin","year":"2020","unstructured":"Kennedy-Martin, M., Slaap, B., Herdman, M., et al. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. European Journal of Health Economics, 21, 1245\u20131257. https:\/\/doi.org\/10.1007\/s10198-020-01195-8","journal-title":"European Journal of Health Economics"},{"key":"4414_CR5","doi-asserted-by":"crossref","unstructured":"de Vet, H. C., Terwee, C. B., & Mokkink, L. B. (2024). Minimal important difference. Encyclopedia of Quality of Life and Well-Being Research 4390\u20134392.","DOI":"10.1007\/978-3-031-17299-1_1813"},{"key":"4414_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0272989X05276863","volume":"25","author":"B Barrett","year":"2005","unstructured":"Barrett, B., Brown, D., Mundt, M., & Brown, R. (2005). Sufficiently important difference: expanding the framework of clinical significance. Medical decision making, 25, 250\u2013261.","journal-title":"Medical decision making"},{"key":"4414_CR7","doi-asserted-by":"publisher","unstructured":"Cheng, L. J., Chen, L. A., Cheng, J. Y., et al. (2024). Systematic review reveals that EQ-5D minimally important differences vary with treatment type and may decrease with increasing baseline score. Journal Of Clinical Epidemiology, 174. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111487","DOI":"10.1016\/j.jclinepi.2024.111487"},{"key":"4414_CR8","doi-asserted-by":"crossref","unstructured":"Al Sayah, F., Jin, X., Short, H., et al. (2025). A Systematic Literature Review of Important and Meaningful Differences in the EQ-5D Index and Visual Analog Scale Scores. Value in Health.","DOI":"10.1016\/j.jval.2024.11.006"},{"key":"4414_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1586\/14737167.2014.894462","volume":"14","author":"S Coretti","year":"2014","unstructured":"Coretti, S., Ruggeri, M., & McNamee, P. (2014). The minimum clinically important difference for EQ-5D index: A critical review. Expert Rev Pharmacoecon Outcomes Res, 14, 221\u2013233.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4414_CR10","doi-asserted-by":"publisher","unstructured":"Young, C. A., Mills, R. J., & Tennant, A. (2025). Preference-Based Assessments EQ-5D-5L in Multiple Sclerosis: Estimated Utility Values, Minimal (Clinically) Important Changes, and Direct and Indirect Influences Over Time. Value in Health. https:\/\/doi.org\/10.1016\/j.jval.2025.07.019","DOI":"10.1016\/j.jval.2025.07.019"},{"key":"4414_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1474-4422(24)00309-0","volume":"23","author":"JA Allen","year":"2024","unstructured":"Allen, J. A., Lin, J., Basta, I., et al. (2024). Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. Lancet Neurology, 23, 1013\u20131024.","journal-title":"Lancet Neurology"},{"key":"4414_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P. (1997). Modeling Valuations for EuroQol Health States. Medical Care, 35, 1095\u20131108.","journal-title":"Medical Care"},{"key":"4414_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B Van Hout","year":"2012","unstructured":"Van Hout, B., Janssen, M. F., Feng, Y. S., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15, 708\u2013715. https:\/\/doi.org\/10.1016\/j.jval.2012.02.008","journal-title":"Value in Health"},{"key":"4414_CR14","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1007\/s11136-022-03180-5","volume":"31","author":"S Eremenco","year":"2022","unstructured":"Eremenco, S., Chen, W. H., Blum, S. I., et al. (2022). Comparing patient global impression of severity and patient global impression of change to evaluate test\u2013retest reliability of depression, non-small cell lung cancer, and asthma measures. Quality of Life Research, 31, 3501\u20133512. https:\/\/doi.org\/10.1007\/s11136-022-03180-5","journal-title":"Quality of Life Research"},{"key":"4414_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2024.100302","author":"E McCann","year":"2024","unstructured":"McCann, E., Peterson, K. A., Whalley, D., et al. (2024). Psychometric evaluation of the Dysphagia Symptom Questionnaire for adults and adolescents with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology: Global. https:\/\/doi.org\/10.1016\/j.jacig.2024.100302. 3:.","journal-title":"Journal of Allergy and Clinical Immunology: Global"},{"key":"4414_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/MUS.24207","volume":"50","author":"A Breiner","year":"2014","unstructured":"Breiner, A., Barnett, C., & Bril, V. (2014). INCAT disability score: a critical analysis of its measurement properties. Muscle And Nerve, 50, 164\u2013169. https:\/\/doi.org\/10.1002\/MUS.24207","journal-title":"Muscle And Nerve"},{"key":"4414_CR17","first-page":"26","volume":"13","author":"JA Allen","year":"2017","unstructured":"Allen, J. A., Gelinas, D. F., Lewis, R. A., et al. (2017). Optimizing the use of outcome measures in chronic inflammatory demyelinating polyneuropathy. Eur Neurol Rev, 13, 26\u201333.","journal-title":"Eur Neurol Rev"},{"key":"4414_CR18","doi-asserted-by":"crossref","unstructured":"Mouelhi, Y., Jouve, E., Castelli, C., & Gentile, S. (2020). How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual. Life Outcomes 18.","DOI":"10.1186\/s12955-020-01344-w"},{"key":"4414_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","volume":"11","author":"MT King","year":"2011","unstructured":"King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res, 11, 171\u2013184.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4414_CR20","doi-asserted-by":"crossref","unstructured":"Merkies, I. S., van Nes, S. I., Hanna, K., Hughes, R. A. C., & Deng, C. (2010). Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance. Journal of Neurology, Neurosurgery & Psychiatry, 81(11), 1194\u20131199.","DOI":"10.1136\/jnnp.2009.194324"},{"key":"4414_CR21","unstructured":"Norman, G. R., Sloan, J. A., & Wyrwich, K. W. Point\/Counterpoint Interpretation of Changes in Health-related Quality of Life The Remarkable Universality of Half a Standard Deviation."},{"key":"4414_CR22","doi-asserted-by":"crossref","unstructured":"Samsa, G., Edelman, D., Rothman, M. L., et al. (1999). Determining Clinically Important Differences in Health Status Measures A General Approach with Illustration. to the Health Utilities Index Mark II.","DOI":"10.2165\/00019053-199915020-00003"},{"key":"4414_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal Of Clinical Epidemiology, 61, 102\u2013109.","journal-title":"Journal Of Clinical Epidemiology"},{"key":"4414_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073822","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Devji, T., Carrasco-Labra, A., et al. (2023). A step-by-step approach for selecting an optimal minimal important difference. Bmj. https:\/\/doi.org\/10.1136\/bmj-2022-073822","journal-title":"Bmj"},{"key":"4414_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/0272989X10380925","volume":"31","author":"M Palta","year":"2011","unstructured":"Palta, M., Chen, H. Y., Kaplan, R. M., et al. (2011). Standard error of measurement of 5 health utility indexes across the range of health for use in estimating reliability and responsiveness. Medical Decision Making, 31, 260\u2013269. https:\/\/doi.org\/10.1177\/0272989X10380925","journal-title":"Medical Decision Making"},{"key":"4414_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","volume":"7","author":"AG Copay","year":"2007","unstructured":"Copay, A. G., Subach, B. R., Glassman, S. D., et al. (2007). Understanding the minimum clinically important difference: a review of concepts and methods. Spine Journal, 7, 541\u2013546.","journal-title":"Spine Journal"},{"key":"4414_CR27","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/ptj\/78.11.1186","volume":"78","author":"PW Stratford","year":"1998","unstructured":"Stratford, P. W., Binkley, J. M., Riddle, D. L., & Guyatt, G. H. (1998). Sensitivity to change of the Roland-Morris back pain questionnaire: part 1. Physical Therapy, 78, 1186\u20131196.","journal-title":"Physical Therapy"},{"key":"4414_CR28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/ptj\/78.11.1197","volume":"78","author":"DL Riddle","year":"1998","unstructured":"Riddle, D. L., Stratford, P. W., & Binkley, J. M. (1998). Sensitivity to change of the Roland-Morris back pain questionnaire: part 2. Physical Therapy, 78, 1197\u20131207.","journal-title":"Physical Therapy"},{"key":"4414_CR29","unstructured":"n Der Roer, N., Ostelo, R. W. J. G., Bekkering, G. E. Minimal Clinically Important Change for Pain Intensity, Functional Status, and General Health Status in Patients With Nonspecific Low Back Pain."}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04414-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:55:58Z","timestamp":1792666558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4414"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04414-6","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ADHERE study was conducted in accordance with the Declaration of Helsinki and approved by relevant ethics committees. This secondary analysis used previously collected data and did not require additional ethical approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The sponsor commissioned and enabled this study and provided editorial review of the manuscript.","order":2,"name":"Ethics","label":"Role of the funder\/sponsor","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"309"}}